Pineapple Express Cannabis (PNXP) Cash from Financing Activities (2018 - 2025)
Pineapple Express Cannabis' (PNXP) quarterly Cash from Financing Activities came in at -$1783.0 in Q4 2025, down 514.65% year-on-year from $430.0 in Q4 2024, and up 99.76% quarter-over-quarter from -$746871.0 in Q2 2025.
Pineapple Express Cannabis (PNXP) Cash from Financing Activities (2018 - 2025) Analysis & Trends
Pineapple Express Cannabis has disclosed Cash from Financing Activities across 8 years of filings, most recently posting -$1783.0 for Q4 2025.
- Cash from Financing Activities for Q4 2025 came in at -$1783.0, down 514.65% year-over-year; the trailing twelve-month figure through Oct 2025 was -$715797.0 (down 2856.13% YoY), and the FY2025 annual result was $45001.0, changed N/A from the prior year.
- Cash from Financing Activities came in at -$1783.0 for Q4 2025 at Pineapple Express Cannabis, up from -$746871.0 in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $32857.0 in Q1 2025 to a low of -$746871.0 in Q2 2025.
- The 5-year median for Cash from Financing Activities is $4025.0 (2023), against an average of -$38364.1.
- Across the five-year window, Cash from Financing Activities surged 9542.98% in 2023 and plunged 6475.88% in 2025, its largest moves.
- Pineapple Express Cannabis' Cash from Financing Activities stood at $18250.0 in 2021, then sank by 83.02% to $3099.0 in 2022, then sank by 35.46% to $2000.0 in 2023, then tumbled by 78.5% to $430.0 in 2024, then slumped by 514.65% to -$1783.0 in 2025.
- The last three Cash from Financing Activities figures came in at -$1783.0 (Q4 2025), -$746871.0 (Q2 2025), and $32857.0 (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 13.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -840.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -1.48 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | -86.10 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -65.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 1.47 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -77.88 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | -11.62 Mn |
| 10 | Pineapple Express Cannabis | - | - | - | -1,783.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2025 | -1,783.00 |
| Oct 31, 2025 | -1,783.00 |
| Apr 30, 2025 | -746,871.00 |
| Apr 30, 2025 | -746,871.00 |
| Jan 31, 2025 | 32,857.00 |
| Jan 31, 2025 | 32,857.00 |
| Oct 31, 2024 | 430.00 |
| Oct 31, 2024 | 430.00 |
| Apr 30, 2024 | 11,714.00 |
| Apr 30, 2024 | 11,714.00 |
| Jan 31, 2024 | -36,358.00 |
| Jan 31, 2024 | -36,358.00 |
| Oct 31, 2023 | 2,000.00 |
| Oct 31, 2023 | 2,000.00 |
| Jul 31, 2023 | 22,661.00 |
| Jul 31, 2023 | 22,661.00 |
| Apr 30, 2023 | 11,697.00 |
| Apr 30, 2023 | 11,697.00 |
| Jan 31, 2023 | 4,025.00 |
| Jan 31, 2023 | 4,025.00 |